China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 27.53
(-0.72%)
CNY 27.53
(-0.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.32 Billion CNY | -12.43% |
| 2022 | 1.5 Billion CNY | -0.17% |
| 2021 | 1.51 Billion CNY | 3.49% |
| 2020 | 1.45 Billion CNY | -18.21% |
| 2019 | 1.78 Billion CNY | 17.07% |
| 2018 | 1.52 Billion CNY | 57.25% |
| 2017 | 969.28 Million CNY | 62.44% |
| 2016 | 596.7 Million CNY | 71.35% |
| 2015 | 348.23 Million CNY | 28.88% |
| 2014 | 270.2 Million CNY | 94.38% |
| 2013 | 139 Million CNY | 3.68% |
| 2012 | 134.07 Million CNY | 6.38% |
| 2011 | 126.03 Million CNY | 25.91% |
| 2010 | 100.09 Million CNY | 22.76% |
| 2009 | 81.53 Million CNY | 35.39% |
| 2008 | 60.22 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 303.99 Million CNY | 6.68% |
| 2024 Q3 | 229.68 Million CNY | -17.95% |
| 2024 Q2 | 279.94 Million CNY | -7.91% |
| 2023 Q3 | 327.26 Million CNY | -15.42% |
| 2023 Q2 | 386.93 Million CNY | 1.33% |
| 2023 Q1 | 381.86 Million CNY | 5.77% |
| 2023 FY | 1.32 Billion CNY | -12.43% |
| 2023 Q4 | 284.97 Million CNY | -12.92% |
| 2022 Q4 | 361.02 Million CNY | -5.63% |
| 2022 Q1 | 357.33 Million CNY | -2.56% |
| 2022 Q2 | 406.92 Million CNY | 13.88% |
| 2022 FY | 1.5 Billion CNY | -0.17% |
| 2022 Q3 | 382.54 Million CNY | -5.99% |
| 2021 Q1 | 352.67 Million CNY | -4.32% |
| 2021 Q4 | 366.73 Million CNY | -11.64% |
| 2021 Q3 | 415.04 Million CNY | 10.42% |
| 2021 Q2 | 375.87 Million CNY | 6.58% |
| 2021 FY | 1.51 Billion CNY | 3.49% |
| 2020 FY | 1.45 Billion CNY | -18.21% |
| 2020 Q4 | 368.6 Million CNY | -3.21% |
| 2020 Q3 | 380.83 Million CNY | 10.94% |
| 2020 Q2 | 343.27 Million CNY | -6.39% |
| 2020 Q1 | 366.69 Million CNY | -27.95% |
| 2019 Q2 | 448.43 Million CNY | 14.7% |
| 2019 Q4 | 508.96 Million CNY | 16.73% |
| 2019 Q1 | 390.95 Million CNY | -19.79% |
| 2019 FY | 1.78 Billion CNY | 17.07% |
| 2019 Q3 | 435.99 Million CNY | -2.77% |
| 2018 Q2 | 369.56 Million CNY | 27.78% |
| 2018 Q4 | 487.42 Million CNY | 28.94% |
| 2018 FY | 1.52 Billion CNY | 57.25% |
| 2018 Q3 | 378.01 Million CNY | 2.29% |
| 2018 Q1 | 289.21 Million CNY | -27.18% |
| 2017 FY | 969.28 Million CNY | 62.44% |
| 2017 Q2 | 229.08 Million CNY | 67.46% |
| 2017 Q3 | 206.26 Million CNY | -9.96% |
| 2017 Q1 | 136.79 Million CNY | -30.81% |
| 2017 Q4 | 397.14 Million CNY | 92.55% |
| 2016 FY | 596.7 Million CNY | 71.35% |
| 2016 Q4 | 197.71 Million CNY | 29.02% |
| 2016 Q1 | 101.63 Million CNY | -14.96% |
| 2016 Q2 | 144.11 Million CNY | 41.79% |
| 2016 Q3 | 153.24 Million CNY | 6.34% |
| 2015 Q1 | 66.02 Million CNY | -23.35% |
| 2015 Q3 | 86.58 Million CNY | 13.76% |
| 2015 Q4 | 119.52 Million CNY | 38.04% |
| 2015 Q2 | 76.1 Million CNY | 15.28% |
| 2015 FY | 348.23 Million CNY | 28.88% |
| 2014 Q2 | 62.39 Million CNY | 19.61% |
| 2014 Q1 | 52.16 Million CNY | 40.8% |
| 2014 FY | 270.2 Million CNY | 94.38% |
| 2014 Q4 | 86.12 Million CNY | 23.92% |
| 2014 Q3 | 69.5 Million CNY | 11.39% |
| 2013 Q3 | 35.47 Million CNY | 3.55% |
| 2013 Q4 | 37.05 Million CNY | 4.46% |
| 2013 FY | 139 Million CNY | 3.68% |
| 2013 Q1 | 32.22 Million CNY | -6.71% |
| 2013 Q2 | 34.25 Million CNY | 6.3% |
| 2012 FY | 134.07 Million CNY | 6.38% |
| 2012 Q4 | 34.54 Million CNY | -5.99% |
| 2012 Q2 | 30.4 Million CNY | -6.08% |
| 2012 Q3 | 36.74 Million CNY | 20.86% |
| 2012 Q1 | 32.37 Million CNY | -2.21% |
| 2011 Q1 | 27.53 Million CNY | 0.0% |
| 2011 FY | 126.03 Million CNY | 25.91% |
| 2011 Q2 | 36.15 Million CNY | 31.3% |
| 2011 Q3 | 29.23 Million CNY | -19.15% |
| 2011 Q4 | 33.1 Million CNY | 13.25% |
| 2010 FY | 100.09 Million CNY | 22.76% |
| 2009 FY | 81.53 Million CNY | 35.39% |
| 2008 FY | 60.22 Million CNY | 0.0% |